For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope. In a new study ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...

Scientists at NYU Langone discovered that blocking a key protein that shields cancer cells from a natural stress-driven death process can dramatically slow lung tumor growth.

Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells ...

Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...

Lung cancer develops when lung cells undergo genetic alterations, such as fusions, deletions, or mutations. These changes ...

This summer, 75-year-old Antioch Township Treasurer and Mesick resident Kathy Soerries was preparing for a family vacation to ...

LOS ANGELES, April 18 (Reuters) - Testing lung cancer patients for tumor markers would enable doctors to choose which drug the patient is most likely to respond to, improving the chances for ...

Her physician ordered CyPath® Lung for further risk assessment. The CyPath® Lung test, reported on March 4, 2025, returned a high score of 0.72, indicating the likelihood of cancer. Based on the ...

Humphrey traveled from Michigan to Chicago to seek a second opinion at Northwestern Medicine in May 2024. A bronchoscopy ...